Biomednewsbreaks - Nrx Pharmaceuticals, Inc. (NASDAQ: NRXP) Completes FDA Type C Meeting For NRX-100 NDA Pathway February 18, 2026 depression ONLY AVAILABLE IN PAID PLANS. Originally reported by menafn. Read more Source: https://menafn.com/1110753296/Biomednewsbreaks-Nrx-Pharmaceuticals-Inc-NASDAQ-NRXP-Completes-FDA-Type-C-Meeting-For-NRX-100-NDA-Pathway
